WHO Features Brazil At High Level Media Briefing – Despite Bolsonaro’s Poor Pandemic Leadership 30/04/2021 Kerry Cullinan While India’s COVID-19 pandemic continues to burn through that country’s health system, concerns are mounting that Latin America may become the next global pandemic flashpoint — issues that the World Health Organization (WHO) is rightly trying to highlight to its broad global constituency of policymakers, influencers, and the general public. All the more reason why […] Continue reading -> China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries 28/04/2021 Kerry Cullinan As India restricts COVID-19 vaccine exports to address its domestic surge, the World Health Organization (WHO) is poised to give the Chinese vaccine, Sinopharm, emergency use listing (EUL) this week – potentially catapulting China into becoming the biggest global supplier of COVID-19 vaccines for low- and middle-income countries (LMIC). However, Sinopharm is reported to be […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> Posts navigation Older postsNewer posts
China May Become World’s Biggest Vaccine Supplier As India Defaults On Global Deliveries 28/04/2021 Kerry Cullinan As India restricts COVID-19 vaccine exports to address its domestic surge, the World Health Organization (WHO) is poised to give the Chinese vaccine, Sinopharm, emergency use listing (EUL) this week – potentially catapulting China into becoming the biggest global supplier of COVID-19 vaccines for low- and middle-income countries (LMIC). However, Sinopharm is reported to be […] Continue reading -> The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> Posts navigation Older postsNewer posts
The ‘Patent Bargain’, Public Good & COVID19 26/04/2021 Priti Patniak/Geneva Health Files As the hotly contested proposal for an IP waiver on COVID-related health products comes up again for debate on Friday, 30 April at the World Trade Organization’s TRIPS Council, legal expert Hyo Yoon Kang looks at the foundations of IP law to challenge “TRIPS waiver” naysayers. Geneva Health Files [GHF]: You have argued that IP […] Continue reading -> ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> Posts navigation Older postsNewer posts
ACT-Accelerator Celebrates 1st Anniversary Amid COVID-19 Surge in India 23/04/2021 Kerry Cullinan One of the few silver linings of the COVID-19 pandemic is the unprecedented collaboration of every sector of society to overcome it – best demonstrated by the Access to COVID-19 Tools Accelerator (ACT-Accelerator), which celebrated its first anniversary on Friday. The ACT-Accelerator’s most famous pillar is the vaccine facility, COVAX, which has distributed almost 40 […] Continue reading -> UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> Posts navigation Older postsNewer posts
UK Study Shows Similar, Significant Reductions In COVID-19 Infections With Single Dose Of Oxford-AstraZeneca Or Pfizer-BioNTech Vaccine 23/04/2021 Raisa Santos COVID-19 infections fell significantly – by 65% percent – after a first dose of either the Oxford-AstraZeneca or the Pfizer-BioNTech vaccine in a study of more than 373,000 British residents who received one of the two jabs. The first in a series of two new studies, published by the University of Oxford, found that the […] Continue reading -> DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> Posts navigation Older postsNewer posts
DRC Finally Launches COVID-19 Vaccinations After Investigating Concerns About AstraZeneca 19/04/2021 Kerry Cullinan Six weeks after receiving 1.7 million doses of the AstraZeneca COVID-19 vaccine from COVAX, the Democratic Republic of Congo (DRC) finally started to vaccinate people on Monday. The delay followed concerns about the safety of the vaccine amid reports about possible links between the vaccine and blood clotting. In a bid to build public confidence, […] Continue reading -> People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> Posts navigation Older postsNewer posts
People Might Need a 3rd COVID-19 Vaccine Booster, says Pfizer CEO 19/04/2021 Chandre Prince People are “likely” to need a third dose of the coronavirus vaccine within 12 months of getting the first two doses of the Pfizer-BioNTech vaccine, Pfizer CEO Albert Bourla said during a recent interview. The third booster jab could be necessary “somewhere between six and 12 months” after the second one and possibly even annually, […] Continue reading -> Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> Posts navigation Older postsNewer posts
Increased Funding For Leading Infectious Diseases; Neglected Disease Funding Stagnant 16/04/2021 Raisa Santos Global funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB, and malaria, was US $3.876 billion, with the drop of US $185 million from 2018 reflecting COVID-related difficulties in data collection, according to the G-Finder Report, which tracks annual global investments. However, once participation is accounted […] Continue reading -> Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> Posts navigation Older postsNewer posts
Growing Consensus Emerging At WTO – Strengthen Supply Chain & Tech Transfer To Expand Vaccine Access 15/04/2021 Svĕt Lustig Vijay A growing consensus seems to be emerging out of this week’s high-level WTO meeting that glaring inequities in access to vaccines can be remedied by strengthening supply chains, avoiding export bans across borders, and ensuring that big pharma voluntarily transfers its vaccine technologies to poorer countries so they can produce their own vaccines. “The significant […] Continue reading -> Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> Posts navigation Older postsNewer posts
Many Africans May Not Receive Their Second COVID-19 Vaccine Doses Anytime Soon, Africa CDC Warns 15/04/2021 Paul Adepoju IBADAN – The Africa CDC has expressed concerns over the disruption of the COVID-19 vaccination drive in Africa saying it was preventing many Africans who have received the first dose of the Oxford/AstraZeneca vaccine may not be able to receive the second dose 12 weeks after the first dose as recommended in the vaccination guideline. […] Continue reading -> Posts navigation Older postsNewer posts